FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new compounds, namely nalmefene prodrugs of formula (I) wherein R1 means C16-20alkyloxycarbonylC2-4alkyl, as well as to pharmaceutical compositions containing the above compounds, as well as to a method for preparing the above compounds.
EFFECT: compounds possess action of an opioid receptor antagonist and may be used for treating substance abuse disorders, wherein the above disorder represents abuse of alcohol and alcohol dependence.
8 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
NALMEFENE PRODRUGS | 2009 |
|
RU2495042C2 |
ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
ORGANIC COMPOUNDS | 2018 |
|
RU2780002C2 |
CHROMON OXIME NEW DERIVATIVE AND ITS USE AS ALLOSTERIC MODULATOR OF METABOTROPIC GLUTAMATE RECEPTORS | 2015 |
|
RU2672569C2 |
ORGANIC COMPOUNDS | 2017 |
|
RU2743513C2 |
INHIBITORS OF PHOSPHODIESTERASE 10 ENZYME | 2013 |
|
RU2667058C2 |
PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATMENT OR PREVENTION OF DISORDER OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2776800C2 |
ORGANIC COMPOUNDS | 2019 |
|
RU2809023C2 |
NEW COMPOSITIONS | 2021 |
|
RU2771565C1 |
ORGANIC COMPOUNDS | 2015 |
|
RU2709786C2 |
Authors
Dates
2013-10-10—Published
2009-04-23—Filed